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Purpose. The purpose of this work was to study the influence of cell
differentiation on the mRNA expression of transporters and channels
in Caco-2 cells and to assess Caco-2 cells as a model for carrier-
mediated drug transport in the intestines.
Method. Gene mRNA expression was measured using a custom-
designed microarray chip with 750 deoxyoligonucleotide probes
(70mers). Each oligomer was printed four times on poly-lysine-
coated glass slides. Expression profiles were expressed as ratio val-
ues between fluorescence intensities of Cy3 and Cy5 dye-labeled
cDNA derived from poly(A) + RNA samples of Caco-2 cells and
total RNA of human intestines.
Results. Significant differences in the mRNA expression profile of
transporters and channels were observed upon differentiation of
Caco-2 cells from 5 days to 2 weeks in culture, including changes for
MAT8, S-protein, and Nramp2. Comparing Caco-2 cells of different
passage number revealed few changes in mRNAs except for GLUT3,
which was down-regulated 2.4-fold within 13 passage numbers.
Caco-2 cells had a similar expression profile when either cultured in
flasks or on filters but differed more strongly from human small and
large intestine, regardless of the differentiation state of Caco-2 cells.
Expression of several genes highly transcribed in small or large in-
testines differed fourfold or more in Caco-2 cells.
Conclusions. Although Caco-2 cells have proven a suitable model for
studying carrier-mediated transport in human intestines, the ex-
pression of specific transporter and ion channel genes may differ
substantially.
KEY WORDS: transporters; ion channels; microarrays; Caco-2 cells;
intestinal drug transport.
INTRODUCTION
Drug absorption appears to occur predominantly via pas-
sive transcellular and paracellular transport mechanisms (1).
However, recent studies indicate that carrier-mediated drug
transport may play a more important role than previously
thought. Sequencing of the human genome has suggested the
presence of 406 genes encoding ion channels and 883 encod-
ing transporters, of which 350 are intracellular transporters
(2). Generally, these proteins establish the electrochemical
gradient across membranes and provide the means for trans-
porting amino acids, dipeptides, monosaccharides, monocar-
boxylic acids, organic cations, phosphates, nucleosides, and
water-soluble vitamins (3,4). Frequently, transporters play a
direct role in drug absorption, in particular from the intes-
tines. The hPept1 transporter for instance is responsible for
the carrier-mediated uptake of various peptide-like drugs,
such as cephalexin, Angiotonsin converting enzyme (ACE)
(1) inhibitors, and 5-amino acid esters of the antiviral nucleo-
sides acyclovir and AZT (5,6). L-Val-acyclovir is a prodrug
for which the bioavailability was remarkably increased by a
drug carrier, i.e., hPepT1. Further examples include pravas-
tatin and salicylic acid, which are transported by a monocar-
boxylic acid transporter (7,8). However, transporters can also
limit drug absorption through secretion into the intestinal lu-
men. P-glycoprotein, a member of the ABC superfamily
(ABCB1, MDR1) is a prominent efflux pump, which limits
the uptake of substrates, such as digoxin and cyclosporin
(9,10). Further members of the ABC family might also con-
tribute to reduced drug bioavailability.
Human adenocarcinoma cells, Caco-2, derived from a
colon carcinoma, serve as a common in vitro model for esti-
mating the fraction of compound absorbed via the intestinal
tracts (11). The majority of drugs were thought to be passively
transported. The fraction of a dose absorbed in vivo corre-
lates significantly with the permeability of passively trans-
ported compounds across the Caco-2 cells (12). If, however,
the compound is absorbed by a carrier-mediated mechanism,
correlations are often spurious. This could be related to dif-
ferences in the expression of genes between Caco-2 cells and
intestines that are involved in drug uptake, such as transport-
ers and ion channels. Moreover, Caco-2 cells express different
phenotypes, i.e., resembling colon crypt cells, small intestinal
absorptive enterocytes, and follicle-associated epithelium en-
terocytes (13); therefore, differentiation status and passage
number could strongly affect expression of transporters and
ion channels.
For a majority of drugs, it remains unknown which trans-
porters play a role in their absorption and targeting in the
body. The human genome project has made it possible to
identify most if not all genes encoding transporters and ion
channels. This provokes the challenge to determine which
transporters interact with any given drug at a genomic scale.
A first step in identifying genes relevant to drug absorption in
the intestines is to obtain a catalog of all expressed mRNAs.
In this study, we used a custom-designed oligonucleotide ar-
ray to determine the mRNA expression profiles of transport-
ers and ion channels in Caco-2 cells at different passage num-
ber and differentiation state, in comparison with mRNA pro-
files in human intestines. Also, we compared mRNA profiles
from small intestine and colon to assess the feasibility of tar-
geting carrier-mediated drugs via different segments in the
intestine. The results will be useful in understanding intestinal
drug absorption at the molecular level.
MATERIALS AND METHODS
Materials
FastTrack Kit 2.0 and tRNA were obtained from Invi-
trogen (Carlsbad, CA, USA). Media for cell culture were
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from Cell Culture Facility at UCSF (San Francisco, CA,
USA). Material for coating of slides, succinic anhydride and
poly(A) + RNA was purchased from Sigma (St. Louis, MO,
USA), Gold Seal Microslides from Fisher Scientific (Tustin,
CA, USA), and Fluorolink Cy5 Monofunctional Dye 5 and
Fluorolink Cy3 Monofunctional Dye 3 from Amersham (Pis-
cataway, NJ, USA). Total RNA from colon (Lot# 1050229,
pool from two healthy male Caucasians, age 35 and 50 years)
and small intestine (Lot# 1070366, pool from five healthy
male and female Caucasians, age between 20 and 65 years)
was obtained from Clontech (Palo Alto, CA, USA). Extrac-
tion of total RNA was performed by phenol extraction ac-
cording to a company internal protocol. Oligomers were or-
dered from MWG (High Point, NC, USA).
Cell Culture
Caco-2 cells passages 81 to 98 were cultured in Dulbec-
co’s modified Eagle’s medium with 4.5 g/L of D-glucose),
which was supplemented with 20% fetal bovine serum, non-
essential amino acids (1% v/v), and 100 units/mL penicillin
and 100 g/mL streptomycin. Confluent monolayers were
subcultured every 7 days by treatment with 0.5% trypsin and
0.2% EDTA and seeding at a density of 5 × 105 cells/80 cm2
into plastic flasks. Cultures were incubated at 37°C in a hu-
midified atmosphere of 5%/95% CO2/O2. For mRNA expres-
sion measurements in flasks, cells were seeded at a density of
1.5 × 106 cells/175 cm2, for mRNA expression studies in fil-
ters, at a density of 3.75 × 105 cells/44 cm2 on polycarbonate
inserts (Costar Transwell, mean pore diameter of 0.4 m).
The transepithelial electrical resistance (TEER) was mea-
sured with a Millicell-ERS (Millipore, Corp., Bedford, MA,
USA).
Selection of Genes
Hidden Markov Models (HMMs) of transporter and ion
channel genes were selected by searching the Pfam Database
6.1 (http://pfam.wustl.edu/) with keywords and seed se-
quences chosen from known transporter and channel families
(http://www-biology.ucsd.edu/∼msaier/transport/toc.html).
HMMs were run against the Genpept database using
hmmsearch/hmmer-2.1.1-intel-linux (http://hmmer.wustl.
edu/). Only hits with a probability of 0.0001 or lower were
selected. Using the multiple alignment program ClustalW, re-
dundant accession numbers were filtered out. In addition,
new putative transporter and channel gene sequences were
collected. An automated search method was applied that uses
converged PSI-Blast against the human expressed sequence
tags (EST) (1) database for identification of new gene candi-
dates (14). Resulting contig sequences representing two or
more overlapping ESTs were used for the array. Because this
work was performed before the release of the human se-
quence, contigs identified in our search were then run against
the human genome database, and annotated genes matching
the contigs were identified. Several contigs did not match any
annotated genes and, therefore, might represent yet unchar-
acterized genes. Identity of these putative genes will be stud-
ied separately. Housekeeping genes and negative controls
were the same as in the Atlas 1.2 Human Array by Clontech.
Design of Oligomers
Coding region sequences only were used for the design of
the oligomers. To select the 70mers, an algorithm was applied
that takes the following four criteria into account: uniqueness,
internal palindrome structure (reverse Smith-Waterman algo-
rithm is used to detect palindrome sequence), melting tem-
perature, and localization of the 70mer probe within the gene
sequence (15). For the design of the 70mers, a melting tem-
perature of 70°C, an internal palindrome structure value of
100, and a uniqueness cutoff of 15 bp were chosen. All oligo-
mers were designed to be located as close toward the 3 end
as possible. A list of all genes on the chip, including sequences
of the 70mers, will be published on AAPS PharmSci, (URL to
be provided.)
Preparation of Microarray Chips
Glass slides were coated according to DeRisi et al. (16).
Oligomers were printed at a concentration of 33 M in 3 ×
SSC. The entire set of 750 oligos was printed four times on
each glass slide. After printing, slides were treated with suc-
cinic anhydride before hybridization to block poly-L-lysine
(16).
Preparation of Poly(A) + RNA, Labeling, Hybridization,
and Scanning
Poly(A) + RNA was extracted from cells using the Fast-
Track 2.0 Kit by Invitrogen. Samples of 2 g poly(A) + RNA
or 20 g total RNA, respectively, were labeled with either
Cy3 Dye or Cy5 Dye by amino-allyl coupling (http://
derisilab.ucsf.edu/pdfs/amino-allyl-protocol.pdf,), resus-
pended in 20 L of HEPES buffer (25 mM, pH 7.0) contain-
ing 1 L of tRNA, 1.5 L of yeast poly(A)+ RNA, 0.45 L of
10% SDS, and hybridized to the slides for 16 h at 65°C. For
all hybridization reactions comparing Caco-2 cells poly(A) +
RNA was used, whereas for hybridization reactions with hu-
man tissue samples total RNA was used. Cells grown in flasks
had passage numbers between 81 and 82. For studies in filters,
two sets of experiments were done. In the first set, cells had
passage numbers between 82 and 98 and in the second set
between 82 and 85. Slides were washed and dried before scan-
ning according to DeRisi et al. (16). Slides were scanned on a
GenePix 4000A (Foster City, CA, USA) to detect Cy3 and
Cy5 fluorescence.
Quantitative Real-Time Polymerase Chain
Reaction (RT-PCR)
Single-stranded DNA was prepared from Caco-2 total
RNA using oligo-dT priming (Thermoscript RT Kit, Invitro-
gen, Carlsbad, CA, USA), and the same batch of ssDNA was
used in all subsequent mRNA-profiling reactions. RT-PCR
was performed using the MJ Research Opticon and SYBR-
green detection (Applied Biosystems, Foster City, CA, USA).
The threshold cycle for PCR products was defined as the
cycle at which the SYBR green fluorescent signal was 20 stan-
dard deviations above background fluorescence. The thresh-
old cycle for beta-actin and GAPDH mRNA was used to
normalize ssDNA for comparison between samples. Calibra-
tions were performed using known concentrations of plasmid
cDNA or amplified PCR product. PCR products were
checked for appropriate size by gel electrophoresis and were
sequenced to verify specificity. For routine studies, melt peak
analysis was performed at the end of quantitative PCR ex-
periment to evaluate amplification of the correct product. In
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all, ∼60 mRNAs encoding transporters were analyzed by
RT-PCR. A full report on these data will be provided sepa-
rately. Sequences of the PCR primers are available upon
request.
Analysis of Data
Background subtraction and calculation of average of
medians was conducted using GenePix Software 3.0 (Foster
City, CA, USA). Cut-off values for selecting differentially
expressed genes were based on control studies, i.e., hybrid-
ization of identical, but differently labeled poly(A+) RNA.
For hybridization studies with combined RNA sources, i.e.,
total RNA and ploly (A) + RNA, more stringent cut-off val-
ues were applied. K-means clustering was done using Spotfire
software (Somerville, MA, USA).
RESULTS
Selection of Transporter and Ion Channel Genes
Seventy-nine HMMs were run against the GenePept DB
representing various gene families encoding transporters, ion
exchangers, and ion channels. The resulting gene sequences
were compared with an existing transporter and ion channel
database (http://www.aapspharmsci.org/scientificjournals/
pharmsci/journal/20.html). A total 670 transporter genes and
261 channel genes (including splice variants) were collected.
The search for putative new genes by using a converged PSI-
Blast against the human EST database (14) resulted in 236
contigs that differed from known genes. For some gene se-
quences, 70mer probes could not be designed under the speci-
fied conditions. These were either sequences containing
single nucleotide polymorphisms or splice variants of known
genes. In these cases, a probe sequence was chosen that rep-
resented all splice variants. In the case of single nucleotide
polymorphisms an oligomer was designed that did not contain
the SNP site. After eliminating duplicated sequences, 316
oligomers were designed for transporter genes, 151 for chan-
nel genes, 156 for contigs representing putative transporter
genes not in the nr database at the time (∼January 2001), and
12 for controls. In addition to the above-mentioned genes, the
array contained 100 genes representing RGS, ADAM, and
EGF-like gene families. These are not further considered in
the present study.
Passage Number and Differentiation in Caco-2 Cells
Caco-2 cells were grown over a period of 3 weeks. Under
the conditions used, the cells were confluent after 1 week
when grown in flasks. When cultured on filters, the TEERs
increased between 5 days and 2 weeks and remained stable
between 2 weeks and 3 weeks, indicating that cells were dif-
ferentiated after 2 weeks. For all studies in flasks, Caco-2 cells
with passage numbers between 81 and 83 were used, whereas
for studies on filters, cells with passage numbers ranging from
82 to 98 were used. To test the error associated with measur-
ing relative mRNA levels between two samples, we compared
two identical poly(A) + samples obtained from Caco-2 cells
cultured for 5 days, labeled with Cy3 or with Cy5. The mean
intensity values for Cy3 and Cy5 fluorescence, from four ob-
servations for each probe (spotted four times on a single
slide), were plotted as shown in Fig. 1. The scatter along the
diagonal is acceptable, and there are no outliers. Deviations
from the line of unity were 1.5-fold maximally. Using three
replicate slides, or a total of 12 observations, a change of 1.3-
to 1.5-fold in mRNA expression level over the control can be
reliably measured, depending upon the probe and fluores-
cence intensity of the signal. Thus, we used as a cut-off 0.45
for the log2 ratio values, unless noted otherwise.
To assess the influence of passage number on the mRNA
expression profile, we compared cells that were grown on
filters with passage numbers 85 and 98 (cf. Fig. 1, insert).
Table I shows all genes that were significantly up- or down-
regulated. GLUT3 was the only gene that showed a 2-fold
change in mRNA expression between the different passage
numbers. A few genes displayed a change in mRNA expres-
sion of 1.5-fold or higher, indicating that the cellular pheno-
type does change detectably with passage number.
The next series of experiments addressed the question
how the mRNA expression profile changes with differentia-
tion of Caco-2 cells. Poly(A) + RNAs of cells cultured for 5
days, 1 week, 2 weeks, and 3 weeks were fluorescently labeled
and their mRNA expression profiles analyzed. Over a period
of 3 weeks, the mRNA expression profile changed markedly.
Figures 1–4 show the fluorescence intensity of Cy3 labeled
mRNA of 5-day-old cells (Cy3) vs. the fluorescence of Cy5-
labeled mRNA of 1-, 2-, and 3-week-old cells. Changes occur
mainly between 5 days and 1 week and between 1 week and
2 weeks (cf. Fig. 5). Tables II and III show all genes that are
significantly up- or down-regulated over a period of 3 weeks.
Only a few genes had a 2-fold or higher change in mRNA
expression levels measured by the ratio value. There were no
major differences observed between cells grown on filters or
in plastic flasks. All genes that had a 2-fold or higher change
in mRNA expression ratio in cells grown on flasks were simi-
larly regulated in cells grown on filters. Figure 6 shows the
Fig. 1. Comparison of flourescence intensities of identical mRNA
samples from 5-day Caco-2 cells passage 82 grown in flasks, labeled
with Cy3 or Cy5, respectively. Scatter represents the analytical error.
Insert shows comparison of 5-day Caco-2 cells passage 85 vs. 95.
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K-means clustering of relative mRNA expression levels in
flask and filters. This groups genes together that have a simi-
lar mRNA expression profile over the time course of differ-
entiation. Clusters 8 to 12 show genes that are more dynami-
cally regulated over time than genes represented in clusters 1
to 7. Clusters 8 and 12 contain genes that show a trend to
down regulation upon differentiation, whereas clusters 10 and
11 contain genes with a trend to up regulation. In summary,
transporter genes that that are up-regulated upon differentia-
tion include GLUT5, amino acid and ion transporters, such as
Nramp2, MAT8, and Na+,K+-ATPase, whereas amino acid
transporter E16 and the glucose transporter GLUT3 were
Fig. 2. Comparison of flourescence intensities of mRNA samples
from 5-day and 1-week Caco-2 cell cultures (all passage P82) grown
in flasks, labeled with Cy3 or Cy5, respectively.
Fig. 3. Comparison of flourescence intensities of mRNA samples
from 5-day (P82) and 2-week Caco-2 cell cultures (P81) grown in
flasks, labeled with Cy3 or Cy5, respectively.
Fig. 4. Comparison of flourescence intensities of mRNA samples
from 5-day (P82) and 3-week (P82) Caco-2 cell cultures grown in
flasks, labeled with Cy3 or Cy5, respectively.
Table I. Genes Showing Significant Changes in mRNA Expression
with Increasing Passage Numbers in Caco-2 Cells
Name ID
Log ratio
values SD
ABCG5 gi|11692799 −0.60 0.48
ACCN3 gi|9998947 0.66 0.22
Bak-3 pseudogene gi|595923 0.75 0.10
Ca-act. Cl channel protein gi|5726286 −0.87 0.87
Connexin 59 CX59 gi|9957541 −0.68 0.74
Contig101  protein
similar to AQP7
gi|9367917 −0.89 0.82
Contig103  AQP7 gi|4502186 −0.61 0.50
Contig14  ABCA5 gi|20559208 −0.64 0.52
Contig17  HepG2/SLC2A1 gi|183302 0.62 0.47
Contig171  cofactor
required for Sp1
gi|13937750 −0.63 0.54
Contig223  FLJ23784 gi|18676946 −0.84 0.60
Contig81  SLC7A8,
CAT, y+ system
gi|14751202 0.61 0.33
Electrogenic Na+
bicarbonate cotrans.
gi|4877551 −0.63 0.63
GLUT3 gi|183684 1.26 0.19
LTRPC7 gi|13959784 −0.60 0.37
SLC12A3: Na/Cl transporters gi|4506976 0.71 0.36
SLC21A14: organic anion
transp. polypeptide 14
gi|7839586 −0.81 0.66
SLC30A3, zinc transporter gi|4508042 0.70 0.21
Stromelysin gi|36632 0.74 0.43
TIRC7 gi|3603174 0.63 0.37
Note: Relative mRNA expression levels are log2 ratio values of Cy5
intensities in P95 cells over Cy3 intensities in P85 cells. Cut-off for
log2 ratio values was 0.6 (n  2 × 4).
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significantly down-regulated. In addition, genes of the ABC
superfamily were regulated upon differentiation. The array
contains probes for 40 of the currently known 48 ABC trans-
porter genes—an indication of the overall coverage of the
probe array for a well-defined transporter family (14). No
influence of the state of differentiation was observed for the
dipeptide transporter hPept1 and the monocarboxylic acid
transporters—that is, ratio values were smaller than ∼1.2, i.e,
log2 ratio values were all lower or equal to ∼0.26). This result
is surprising because hPepT1 is thought to be prominently
up-regulated in differentiated Caco-2 cells (17). Other factors,
including protein expression at the cell surface rather than at
intracellular membranes, may play a role in the enhanced
drug/dipeptide transport in differentiated Caco-2 cells.
Quantitative RT-PCR
To validate the results obtained with array, we also mea-
sured mRNA expression by RT-PCR, an accepted quantita-
tive method. With quantitative RT-PCR, an up-regulation of
hPept1 was observed in Caco-2 cells upon differentiation over
2 weeks. In general, RT-PCR was more sensitive in detecting
changes of gene expression during differentiation than the
microarray. All genes with a 5-fold or higher increase over
2 weeks (ABCC2, ABCG1, OCTN1, RBAT, ABCA1,
ABCA5, ABCC3, GLUT5, SLC5A3, NPT-4, DRA) using
RT-PCR were also found to be up-regulated in both flasks
and filters (except NADC1) using the microarray, but with an
average log2 value of only 0.22 in filters and 0.36 in flasks.
However, genes with a log2 value of 0.45 or higher in micro-
arrays (ABCC1, ABCA5, ABCC3, GLUT5, SLC5A3,
OATPRP2) were always confirmed with RT-PCR (Table IV)
Moreover, we compared the mRNA expression of 22 genes
(OAT1, MCT1, MCT3, CAT2, and 18 ABC transporters) that
did not change significantly during 2-week differentiation
measured by RT-PCR (2-fold or lower with RT-PCR), to
results obtained with microarray data. Consistent with the
RT-PCR data, the average log2 value was 0.04 using micro-
arrays, indicating no significant change. With RT-PCR, abso-
lute levels of the mRNAs can be estimated, whereas the array
only detects changes in mRNA expression (because signal
intensity is subject to many variables).
Comparison between Caco-2 Cells and Intestinal Tissue
The mRNA expression of transporter and ion channel
genes in undifferentiated 5-day-old and differentiated
3-week-old Caco-2 cells were compared with mRNA from
human intestinal tissue. Differences between Caco-2 cells and
tissue were more pronounced than between undifferentiated
and differentiated Caco-2 cells. The mRNA expression of
numerous genes differed by 2-fold or more. Genes that are
known to be specifically expressed in defined segments in the
intestine were found to be more highly expressed relative to
Caco-2 (cf. Tables V and VI), such as SCNN1B (18) and colon
mucosa-associated DRA (19) in the colon, and SGLT1 (20)
and CaCC1 (21) in the small intestine. Confirmation of high
mRNA levels for these intestinal tissue-selective genes vali-
dates further the results obtained with the custom-design ar-
ray. As expected, GLUT3 mRNA was at low abundance in
colon and small intestine (22). The mRNA expression of sev-
eral genes that were significantly regulated in Caco-2 cells
upon differentiation was similar between human intestines
and differentiated Caco-2 cells. For example, MAT8, was
strongly up-regulated upon differentiation, reaching a similar
level of mRNA expression as found in colon tissue. In con-
trast, MAT8 was expressed to similar levels in undifferenti-
ated Caco-2 cells and small intestine. Other examples that
showed a similar pattern are S-protein, sulfate transporter
DTD, and Na,K-ATPase b1 gene. No members of the ABC
transporters, the dipeptide transporters, and monocarboxylic
acid transporters had a log ratio value of one or higher. How-
Fig. 5. Plot of relative mRNA expression levels between 2-weeks and 1-week Caco-2 cell cultures and between
2-week and 3-week cell cultures. Points along the diagonal indicate little change in expression ratio between 2-
and 3-week cultures.
mRNA Expression in Caco-2 Cells 7
T
ab
le
II
A
.
G
en
es
T
ha
t
A
re
R
eg
ul
at
ed
in
C
ac
o-
2
C
el
ls
G
ro
w
n
in
F
la
sk
s
ov
er
a
P
er
io
d
of
3
W
ee
ks
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(1
w
ee
k)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(2
w
ee
ks
)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(3
w
ee
ks
)
SD
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
0.
46
0.
50
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
2.
08
0.
82
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
0.
90
0.
32
A
T
A
1
(8
)
gi
|1
16
40
74
2
−
0.
70
0.
59
A
T
A
1
(8
)
gi
|1
16
40
74
2
−
0.
91
0.
64
A
B
C
-1
(5
)
gi
|4
12
80
32
0.
61
0.
61
A
B
C
-1
(5
)
gi
|4
12
80
32
0.
61
0.
48
A
B
C
C
3
(6
)
gi
|9
95
59
69
0.
54
0.
58
A
B
C
C
3
(6
)
gi
|9
95
59
69
0.
47
0.
56
C
on
ti
g8

A
B
C
A
5
(4
)
gi
|2
05
59
20
8
0.
46
0.
41
C
on
ti
g8

A
B
C
A
5
(4
)
gi
|2
05
59
20
8
0.
52
0.
22
G
L
U
T
3
(9
)
gi
|1
83
68
4
−
0.
72
0.
24
G
L
U
T
3
(9
)
gi
|1
83
68
4
−
0.
76
0.
52
Im
po
rt
in
al
ph
a
3
(8
)
gi
|1
92
89
74
−
0.
58
0.
50
Im
po
rt
in
al
ph
a
3
(8
)
gi
|1
92
89
74
−
0.
73
0.
62
M
A
T
8
(1
1)
gi
|1
08
50
25
−
0.
49
0.
47
M
A
T
8
(1
1)
gi
|1
08
50
25
1.
42
0.
51
M
A
T
8
(1
1)
gi
|1
08
50
25
1.
85
0.
42
N
a,
K
-A
T
P
as
e
b1
(1
0)
gi
|8
06
75
3
0.
86
0.
23
N
a,
K
-A
T
P
as
e
b1
(1
0)
gi
|8
06
75
3
0.
67
0.
80
N
R
A
M
P
2
(1
0)
gi
|3
86
91
52
0.
68
0.
32
N
R
A
M
P
2
(1
0)
gi
|3
86
91
52
1.
10
0.
40
P
M
P
70
(9
)
gi
|3
55
52
−
0.
70
0.
54
P
M
P
70
(8
)
gi
|3
55
52
−
0.
91
0.
60
R
C
H
1
(8
)
gi
|7
91
18
4
−
0.
56
0.
36
R
C
H
1
(8
)
gi
|7
91
18
4
−
0.
60
0.
43
S-
pr
ot
ei
n
(1
1)
gi
|3
65
74
1.
38
0.
34
S-
pr
ot
ei
n
(1
1)
gi
|3
65
74
1.
69
0.
41
SU
R
2
(8
)
gi
|3
12
71
38
−
0.
48
0.
43
SU
R
2
(8
)
gi
|3
12
71
38
−
0.
50
0.
52
SU
R
2
(8
)
gi
|3
12
71
38
−
0.
55
0.
68
T
im
17
a
(8
)
gi
|4
37
85
28
−
0.
56
0.
61
T
im
17
a
(8
)
gi
|4
37
85
28
−
0.
65
0.
94
T
IM
23
(8
)
gi
|2
59
91
28
−
0.
67
0.
54
T
IM
23
(8
)
gi
|2
59
91
28
−
0.
84
0.
66
N
ot
e:
R
el
at
iv
e
ex
pr
es
si
on
le
ve
ls
ar
e
lo
g 2
ra
ti
o
va
lu
es
of
C
y5
in
te
ns
it
ie
s
in
1-
,2
-,
an
d
3-
w
ee
k-
ol
d
ce
lls
ov
er
C
y3
in
te
ns
it
ie
s
in
5-
da
y-
ol
d
ce
lls
.C
ut
-o
ff
fo
r
lo
g 2
ra
ti
o
va
lu
es
w
as
0.
45
(n

4
×
3)
.
a
K
-m
ea
ns
cl
us
te
r
nu
m
be
r
ac
co
rd
in
g
to
F
ig
.6
.
Anderle et al.8
T
ab
le
II
B
.
G
en
es
T
ha
t
A
re
R
eg
ul
at
ed
in
C
ac
o-
2
C
el
ls
G
ro
w
n
in
F
la
sk
s
ov
er
a
P
er
io
d
of
3
W
ee
ks
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(1
w
ee
k)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(2
w
ee
ks
)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(3
w
ee
ks
)
SD
B
cl
-x
L
/b
cl
-2
as
s.
de
at
h
pr
om
ot
er
B
(5
)
gi
|2
66
07
28
−
0.
47
0.
52
B
C
L
2/
ad
en
ov
ir
us
E
1B
(1
)
gi
|5
58
84
5
0.
60
0.
44
E
A
A
T
1
(8
)
gi
|4
87
33
8
−
0.
67
1.
37
C
A
T
,y
+
sy
st
em
(1
)
gi
|7
65
76
82
−
0.
60
0.
59
C
on
ti
g2
23

F
L
J2
37
84
(7
)
gi
|1
86
76
94
6
−
0.
47
0.
73
F
C
G
R
T
(6
)
gi
|4
75
83
45
0.
45
0.
35
C
on
ti
g2
22

A
T
P
9B
(3
)
gi
|2
05
54
28
6
−
0.
48
0.
39
SL
C
5A
3:
N
a+
/m
yo
-
in
os
it
ol
co
tr
an
s.
(6
)
gi
|6
62
84
2
0.
46
0.
16
H
K
1
(5
)
gi
|1
84
10
0
−
0.
45
0.
46
C
on
ti
g7
2

cl
on
e
hC
IT
.2
81
_F
_2
4
(3
)
gi
|3
17
67
28
−
0.
56
0.
45
Su
lf
at
e
tr
an
sp
or
te
r
D
T
D
(1
0)
gi
|5
49
98
7
0.
49
0.
30
H
P
T
-1
(1
0)
gi
|4
83
39
1
0.
55
0.
24
C
on
ti
g9

A
B
C
A
6
(7
)
gi
|2
05
59
21
0
−
0.
46
0.
58
O
A
T
P
R
P
2
(1
0)
gi
|1
19
90
58
8
0.
58
0.
33
C
re
at
in
e
tr
an
sp
or
te
r
(3
)
gi
|4
93
13
1
−
0.
46
0.
52
SC
N
10
A
(8
)
gi
|4
83
81
44
−
0.
52
0.
27
hA
SC
T
1
(3
)
gi
|7
65
23
3
−
0.
45
0.
58
SL
C
17
A
4:
so
di
um
ph
os
ph
at
e
(4
)
gi
|4
88
54
40
0.
63
0.
63
St
im
ul
at
or
of
F
e
tr
an
sp
or
t
(7
)
gi
|2
73
89
24
−
0.
47
0.
58
SL
C
3A
2:
ac
t.
of
di
ba
si
c
an
d
ne
ut
ra
l
A
A
T
(8
)
gi
|4
50
51
40
−
0.
51
0.
31
SL
C
21
A
14
:o
rg
an
ic
an
io
n
tr
an
sp
.p
ol
yp
ep
ti
de
14
(7
)
gi
|7
83
95
86
−
0.
52
0.
53
SR
P
1
ho
m
ol
og
(5
)
gi
|9
13
39
2
−
0.
52
0.
69
SL
C
21
A
3:
or
ga
ni
c
an
io
n
tr
an
sp
or
te
r
(4
)
gi
|4
82
70
13
−
0.
49
0.
41
N
ot
e:
R
el
at
iv
e
ex
pr
es
si
on
le
ve
ls
ar
e
lo
g 2
ra
ti
o
va
lu
es
of
C
y5
in
te
ns
it
ie
s
in
1-
,2
-,
an
d
3-
w
ee
k-
ol
d
ce
lls
ov
er
C
y3
in
te
ns
it
ie
s
in
5-
da
y-
ol
d
ce
lls
.C
ut
-o
ff
fo
r
lo
g 2
ra
ti
o
va
lu
es
w
as
0.
45
(n

4
×
3)
.G
en
es
lis
te
d
he
re
re
ac
he
d
th
e
cu
t-
of
f
va
lu
e
at
on
ly
on
e
ti
m
e
po
in
t.
a
K
-m
ea
ns
cl
us
te
r
nu
m
be
r
ac
co
rd
in
g
to
F
ig
.6
.
mRNA Expression in Caco-2 Cells 9
T
ab
le
II
IA
.
G
en
es
T
ha
t
A
re
R
eg
ul
at
ed
in
C
ac
o-
2
C
el
ls
G
ro
w
n
in
F
i lt
er
s
ov
er
a
P
er
io
d
of
3
W
ee
ks
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(1
w
ee
k)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(2
w
ee
ks
)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
-r
at
io
va
lu
es
(3
w
ee
ks
)
SD
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
0.
54
0.
23
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
0.
81
0.
71
A
A
T
E
16
(1
2)
gi
|3
63
90
57
−
1.
46
0.
33
A
T
A
1
( 8
)
g i
|1
1 6
4 0
7 4
2
−
0 .
4 8
0 .
5 7
A
T
A
1
( 8
)
g i
|1
1 6
4 0
7 4
2
−
0 .
5 8
0 .
4 5
M
A
T
8
( 1
1 )
g i
|1
0 8
5 0
2 5
0 .
6 2
0 .
7 3
M
A
T
8
( 1
1 )
g i
|1
0 8
5 0
2 5
0 .
9 2
0 .
6 5
M
A
T
8
( 1
1 )
g i
|1
0 8
5 0
2 5
2 .
2 9
0 .
5 2
N
R
A
M
P
2
(1
0)
gi
|3
86
91
52
0.
77
0.
23
N
R
A
M
P
2
(1
0)
gi
|3
86
91
52
2.
24
0.
19
S-
P
ro
te
in
(8
)
gi
|3
65
74
0.
52
1.
46
S-
P
ro
te
in
(8
)
gi
|3
65
74
1.
92
0.
40
SL
C
21
A
14
:o
rg
an
ic
an
io
n
tr
an
sp
.p
ol
yp
ep
ti
de
14
(7
)
gi
|7
83
95
86
−
0.
53
1.
07
SL
C
21
A
14
:o
rg
an
ic
an
io
n
tr
an
sp
.p
ol
yp
ep
ti
de
14
(7
)
gi
|7
83
95
86
−
0.
50
0.
43
N
ot
e:
R
el
at
iv
e
ex
pr
es
si
on
le
ve
ls
ar
e
lo
g 2
ra
ti
o
va
lu
es
of
C
y5
in
te
ns
it
ie
s
in
1-
,2
-,
an
d
3-
w
ee
k-
ol
d
ce
lls
ov
er
C
y3
in
te
ns
it
ie
s
in
5-
da
y-
ol
d
ce
lls
.C
ut
-o
ff
fo
r
lo
g 2
ra
ti
o
va
lu
es
w
as
0.
45
(n

4
×
3)
.
a
K
-m
ea
ns
cl
us
te
r
nu
m
be
r
ac
co
rd
in
g
to
F
ig
.6
. T
ab
le
II
IB
.
G
en
es
T
ha
t
A
re
R
eg
ul
at
ed
in
C
ac
o-
2
C
el
ls
G
ro
w
n
in
F
ilt
er
s
ov
er
a
P
er
io
d
of
3
W
ee
ks
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(2
w
ee
ks
)
SD
N
am
e
(K
-m
ea
ns
cl
us
te
r)
a
ID
L
og
ra
ti
o
va
lu
es
(3
w
ee
ks
)
SD
B
C
L
2/
ad
en
ov
ir
us
E
1B
19
kD
-i
nt
er
ac
ti
ng
pr
ot
ei
n
1)
gi
|5
58
84
5
0.
53
0.
35
C
on
ti
g1
01

no
ve
l
ge
ne
si
m
ila
r
to
A
Q
P
7
(7
)
gi
|9
36
79
17
−
0.
57
0.
48
C
on
ti
g2
23

F
L
J2
37
84
(7
)
gi
|1
86
76
94
6
−
0.
55
0.
55
C
on
ti
g1
03

A
Q
P
7
(7
)
gi
|4
50
21
86
−
0.
60
0.
56
SL
C
12
A
2:
N
a/
K
/C
l
tr
an
sp
or
te
rs
(8
)
gi
|4
50
69
74
−
0.
55
0.
71
E
A
A
T
1
(8
)
gi
|4
87
33
8
−
0.
69
0.
65
F
C
G
R
T
(6
)
gi
|4
75
83
45
0.
74
0.
54
G
L
U
T
3
(9
)
gi
|1
83
68
4
0.
64
0.
46
G
L
U
T
5
(6
)
gi
|1
83
29
7
1.
10
0.
32
H
ep
G
2
(2
)
gi
|1
83
30
2
0.
76
0.
36
H
P
T
-1
(1
0)
gi
|4
83
39
1
1.
19
0.
14
Im
po
rt
in
al
ph
a
3
(8
)
gi
|1
92
89
74
−
0.
45
0.
28
N
a,
K
-A
T
P
as
e
b-
1
(1
0)
gi
|8
06
75
3
1.
82
0.
22
O
A
T
P
R
P
2
(1
0)
gi
|1
19
90
58
8
1.
23
0.
21
P
M
P
70
(8
)
gi
|3
55
52
−
0.
72
0.
27
R
C
H
1
(8
)
gi
|7
91
18
4
−
0.
69
0.
15
Su
lf
at
e
tr
an
sp
or
te
r
D
T
D
(1
0)
gi
|5
49
98
7
1.
64
0.
41
SU
R
2
(8
)
gi
|3
12
71
38
−
0.
51
0.
32
T
im
17
a
(8
)
gi
|4
37
85
28
−
0.
54
0.
27
N
ot
e:
R
el
at
iv
e
ex
pr
es
si
on
le
ve
ls
ar
e
lo
g 2
ra
ti
o
va
lu
es
of
C
y5
in
te
ns
it
ie
s
in
1-
,2
-,
an
d
3-
w
ee
k-
ol
d
ce
lls
ov
er
C
y3
in
te
ns
it
ie
s
in
5-
da
y-
ol
d
ce
lls
.C
ut
-o
ff
fo
r
lo
g 2
ra
ti
o
va
lu
es
w
as
0.
45
(n

4
×
3)
.G
en
es
lis
te
d
he
re
re
ac
he
d
th
e
cu
t-
of
f
va
lu
e
at
on
ly
on
e
ti
m
e
po
in
t.
a
K
-m
ea
ns
cl
us
te
r
nu
m
be
r
ac
co
rd
in
g
to
F
ig
.6
.
Anderle et al.10
ever, this cut off value is rather stringent as we can detect
smaller changes using four replicate samples per array and
three separate experiments. Table VII lists all members of
these families that were differently regulated in 3-week-old
Caco-2 cells compared with intestinal tissue assuming that a
cut-off value of 0.45 is significant. This includes hPepT1,
which is selectively expressed in small intestines.
Comparison between Colon and Small Intestine
Genes that were found earlier (Tables V and VI) to be
specific for either the colon or the small intestine in compari-
son to differentiated Caco-2 cells were confirmed by direct
comparison of mRNAs from small intestine with colon (cf.
Table VIII). For instance CaCC2, contig90, a gene similar to
CAT, y + system (gi|20485816), and MAT8 were found to be
more highly expressed in colon, and GLUT5 and SGLT1 in
small intestine. By lowering the cut-off value from 0.6 to 0.45,
only three additional members of the ABC transporter, and
the dipeptide transporter hPepT1 were found to be differ-
ently expressed in small intestines and colon: ABCG8 (−0.60
± 0.45), ABCB8 (0.41 ± 0.33), and hPept1 (−0.56 ± 0.24).
DISCUSSION
The importance of carrier-mediated transport on drug
bioavailability remains to be assessed for many drugs. The
large number of transporter genes in the human genome sug-
gests that transport mechanisms may play a pervasive role in
drug absorption and tissue targeting. Moreover, ATPases and
ion channels determine the electrochemical gradient across
the plasma membrane and generate the driving force for pri-
Fig. 6. K-means clustering of relative mRNA expression [log2 (Cy5/Cy3)] levels after 5-day, 1-, 2-, and 3-week cultures in flasks (5*, 1*, 2*,
3*) and on filters (5, 1, 2, 3). Similarity measure: Euclidean distance. Cluster initialization: Data centroid based search. Bar chart shows the
number of genes per each cluster.
Table IV. Comparison of RT-PCR and Microarray
Name ID
Microarray:
log ratio value SD
RT-PCR:
log ratio values
OATPRP2a gi|11990588 1.23 0.21 2.40
GLUT5a gi|183297 1.10 0.32 6.91
ABC-1 gi|4128032 0.61 0.48 5.01
OATPRP2 gi|11990588 0.58 0.33 2.40
ABCA5 gi|20559208 0.52 0.22 2.17
ABCC3 gi|9955969 0.47 0.56 8.29
SLC5A3b gi|662842 0.46 0.16 3.53
Note: Listed are genes with a log2 ratio value of 0.45 or higher using
microarray. Relative mRNA expression levels are log2 ratio values of
Cy5/Cy3 intensities for 3-week vs. 5-day-cell cultures.
a On filters.
b After 2 weeks.
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mary and secondary active transport. The present study pro-
vides a survey of those genes that are expressed in Caco-2
cells and in human intestines, as a first step in understanding
the overall transport capacity of human intestinal tissue rel-
evant to drug bioavailability, and the utility of Caco-2 cell
culture as a model of intestinal drug absorption. Microarray
technology allows one to measure mRNA expression levels of
a large number of genes. We used two methods for identifying
gene targets for our chip: 1) screening the NCBI database for
ESTs that are putative members of transporter/channel fami-
lies (14) and 2) screening the Genepept database with HMMs
that represent transporter and channel genes. This strategy
allowed us to design a chip that contained genes with known
function, putative transporter/channel genes with known
open reading frame, and new putative genes not represented
in NCBI as open reading frames at the time. Upon comple-
tion of the study, we have checked all contigs—assembled
from overlapping ESTs—against the nr database of NCBI,
and have identified those genes that have since been anno-
tated. The newly listed genes represented by contigs are in-
dicated in the tables. For example, among the 48 known ABC
transporter genes, we had probes for 32 genes listed at the
time and for eight contigs representing genes listed subse-
quently. The coverage of our probes may vary from one gene
Table V. Comparison of Genes That Are Differently Regulated in Caco-2 Cells and Colon Tissue
Name ID
Log ratio
values
(5-day) SD Name ID
Log ratio
values
(3-week) SD
CaCCl gi|4585468 1.83 0.69 CaCC1 gi|4585468 1.90 0.63
CLNS1A gi|717053 −1.91 0.65 CLNS1A gi|717053 −1.61 0.66
Colon mucosa-
associated DRA
gi|291963 2.71 0.67 Colon mucosa-
associated DRA
gi|291963 1.86 0.44
Contig90  similar to
CAT, y+ system
gi|20485816 1.85 0.49 Contig90  similar to
CAT, y+ system
gi|20485816 2.41 0.39
GLUT3 gi|183684 −3.56 0.65 GLUT3 gi|183684 −2.51 1.25
NBC4 gi|10864004 1.52 0.13 NBC4 gi|10864004 1.74 0.39
NHE-1 gi|544775 1.55 0.13 NHE-1 gi|544775 1.88 0.21
SCNN1B gi|1004270 2.65 0.32 SCNN1B gi|1004270 3.01 0.35
SLC7A7: CAT, y+
system
gi|4507054 −1.57 1.19 SLC7A7: CAT, y+
system
gi|4507054 −1.73 1.40
S-protein gi|36574 −2.90 1.35 S-protein gi|36574 −4.78 1.55
AAT E16 gi|3639057 −2.63 0.94 Contig226 Contig226 1.70 0.28
EAAT1 gi|487338 −1.56 1.00 Contig81 Contig81 1.55 0.21
MAT8 gi|1085025 1.61 0.37 EAAT5 gi|2076761 1.82 0.35
Sulfate transporter
DTD
gi|549987 1.97 0.28 HepG2 gi|183302 −1.60 1.19
KCNE1 gi|4557686 1.88 0.35
NRAMP2 gi|3869152 −2.49 0.71
P2RX1 gi|4505544 1.61 0.34
Potassium ionic
channel Kv4.3
gi|6644149 1.53 0.14
Note: Relative mRNA expression levels are log2 ratio values of Cy5 intensities in colon tissue over Cy3 intensities in 5-day-old
or 3-week-old cells. Cut-off for log2 ratio values was 1 (n  4 × 3).
Table VI. Comparison of Genes That Are Differently Regulated in Caco-2 Cells and Small Intestinal Tissue
Name ID
Log ratio
values
(5-day) SD Name ID
Log ratio
values
(3-week) SD
CaCCl gi|4585468 2.59 0.98 CaCC1 gi|4585468 1.91 0.89
GLUT3 gi|183684 −3.75 0.74 GLUT3 gi|183684 −2.84 1.05
S-protein gi|36574 −3.70 1.07 S-protein gi|36574 −4.13 1.48
AAT E16 gi|3639057 −2.13 0.43 CLNS1A gi|717053 −1.95 0.87
ATA1 gi|11640742 −1.58 0.54 MAT8 gi|1085025 −2.85 0.74
C1 channel regulatory
protein
gi|717053 −2.13 0.45 Na,K-ATPase
b1
gi|806753 −1.86 0.58
EAAT1 gi|487338 −1.82 0.98 NRAMP2 gi|3869152 −2.40 0.63
HepG2 gi|183302 −1.63 1.08
Karyopherin alpha 3 gi|2190277 −1.96 0.42
RCH1 gi|791184 −1.84 0.51
SGLT1 gi|338054 1.99 0.77
Note: Relative expression levels are log2 ratio values of Cy5 intensities in small intestinal tissue over Cy3 intensities in
5-day-old or 3-week-old cells. Cut-off for log2 ratio values was 1 (n  4 × 3).
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family to another, but in the case of the ABC transporters, it
is 40 of 48 known genes. However, additional genes may exist
that have not yet been annotated; in our search of the human
EST database (14) we have identified numerous EST single-
tons that could not be assembled into contigs. These could
represent unknown transporter genes, but EST singletons
were not included with the microarray.
Many of the genes that are responsible for active trans-
port in the intestine are known to be expressed in Caco-2
cells. Consequently, we investigated the mRNA expression of
Table VII. Comparison of Genes of the ABC Transporter, the Monocarboxylic Acid Transporter, and the Dipeptide
Transporter Families That Are Differently Regulated in Caco-2 Cells and Colon and Small Intestinal Tissue
Name ID
Log ratio values
colon SD Name ID
Log ratio values
small intestine SD
ABC-1 gi|4128032 −0.47 0.61 ABC-1 gi|4128032 −0.60 1.01
Contig 13 
ABCA10
gi|18587266 0.53 0.22 Contig13 
ABCA10
gi|18587266 0.54 0.25
ABCB1 gi|4505768 −0.89 0.51 ABCB1 gi|4505768 −0.81 0.68
ABCB10 gi|9961243 −0.58 0.57 ABCB10 gi|9961243 −0.62 0.53
ABCB6 gi|9955962 0.63 0.15
ABCB7 gi|9665249 −0.79 0.49 ABCB7 gi|9665249 −0.96 0.68
ABCB8 gi|9955964 1.12 0.12 ABCB8 gi|9955964 0.61 0.22
ABCC2 gi|4557480 −0.60 0.37 ABCC2 gi|4557480 −0.65 0.39
ABCD4 gi|4826957 −0.70 0.58
ABCG2 gi|4757849 −0.76 0.48 ABCG2 gi|4757849 −0.72 0.28
ABCG5 gi|11692799 0.61 0.37
ABCG8 gi|11692801 1.12 0.55 ABCG8 gi|11692801 1.16 0.32
CFTR gi|180331 −1.13 0.53
PMP70 gi|35552 −0.67 0.58
hPept1 gi|773587 −0.86 0.87
MCT2 gi|3834394 −0.60 0.41
RF-hPept1 gi|2506042 0.69 0.38 RF-hPept1 gi|2506042 0.53 0.24
SLC16A4 gi|4759113 −1.16 0.89 SLC16A4 gi|4759113 −0.75 0.88
SUR2 gi|3127138 −0.69 0.62
Note: Relative expression levels are log2 ratio values of Cy5 intensities in colon or small intestinal tissue over Cy3 intensities
in 3-week-old cells. Cut-off for log2 ratio values was 0.45 (n  4 × 3).
Table VIII. Comparison of Small Intestinal and Colon Tissue
Name ID
Log ratio
values SD Name ID
Log ratio
values SD
ABCA2 gi|9957466 0.80 0.20 AQP3 gi|9257193 −0.71 0.28
ABCC3 gi|9955969 0.85 0.51 Citrate transporter gi|950003 −0.71 0.44
SERCA3b gi|3004458 0.61 0.30 Contig224  FATP gi|16162902 −0.69 0.28
CaCC2 gi|5726288 0.78 0.67 FPN1 gi|7109248 −0.65 0.29
Contig19  ACATN gi|6042194 0.64 0.30 GLUT5 gi|183297 −0.90 0.36
Contig26 
HepG2/SLC2A1
gi|5730050 0.62 0.23 NADC1 gi|1098556 −0.66 0.25
Contig90  similar to
CAT, y+ system
gi|20485816 0.83 0.36 SERCA3 gi|2052511 −0.78 0.58
KCNE1 gi|4557686 0.89 0.25 SGLT1 gi|338054 −1.53 0.37
MAT8 gi|1085025 0.80 0.52 SLC20A2: phosphate
transporter
gi|5803172 −0.65 0.40
Neurotransmitter
transporter, glycine
gi|5902093 0.61 0.35 SLC9A3R1:
sodium/hydrogen
exchanger
gi|4759139 −0.95 0.29
SCNN1B gi|1004270 0.83 0.51 Sodium-coupled
nucleoside
transporter
gi|4759131 −0.66 0.39
SCNN1G gi|1004272 0.71 0.26
Na channel,
nonvoltage-gated 1
alpha
gi|4506814 0.63 0.43
Note: Relative expression levels are log2 ratio values of Cy5 intensities in small intestinal tissue over Cy3 intensities in colon
tissue. Cut-off for log2 ratio values was 0.6 (n  4 × 3).
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transporter and channel genes in Caco-2 cells and compared
them with small intestine and colon using microarrays. Caco-2
cells spontaneously convert from undifferentiated cells into
polarized cells, requiring the expression of different proteins
at the basolateral and apical sides of the cells. Therefore, we
investigated the impact of differentiation on gene mRNA ex-
pression (23–26) at a genomic level.
Relative mRNA expression levels clearly changed over
time. However, the relative increases of mRNA expression
levels measured by microarrays were smaller than expected
based on quantitative PCR results of some selected genes.
This is common to oligonucleotide arrays measuring mRNA
levels and may be related to a background level of non-
specific binding under the conditions used. However, genes
that were significantly up-regulated, i.e., ∼1.4-fold increase or
higher, could be confirmed by quantitative PCR (GLUT5,
OATPRP2, ABCC3, ABCA5 [Contig8], SLC5A3, ABC1), or
were implicated in Caco-2 cell differentiation in previous
studies on individual genes. Gene mRNA expression changed
during the first 2 weeks and reached a plateau between 2 to 3
weeks, which parallels changes of the TEERs. This pattern
correlates with the stage of morphological differentiation
(27). As shown earlier, Caco-2 cells differentiate spontane-
ously after having reached confluency and are fully differen-
tiated after 2 weeks. Only a few genes were strongly regulated
over time. Most of these genes encode amino acid transport-
ers, sugar transporters, and ion transporters. MAT8, the S-
protein, Nramp2, and Na,K-ATPase b1 had the most signifi-
cant increase in mRNA expression levels. These channels and
transporters are either related to chloride and iron homeo-
stasis of the cells or to cell adhesion (28–31). This indicates
that the development of an ion gradient and cell adhesion are
crucial factors for polarization of the cells.
In human intestines, mRNA expression of a number of
genes differed markedly from that in Caco-2 cells, regardless
of the state of differentiation. For several genes, e.g., MAT8,
Nramp2, Na,K-ATPase b1, EAAT1, and HepG2, differentia-
tion of Caco-2 cells cause changes in mRNA expression that
approximate the mRNA expression found in either small or
large intestines. A few genes were more highly expressed in
Caco-2 than in intestines: GLUT3 and the S-protein. GLUT3
is known to be expressed in Caco-2 cells (32). Earlier studies
have demonstrated that GLUT3 does not appear to be ex-
pressed in healthy intestinal tissue, but it was shown to be
expressed in various tumors (22,33). Hence, the decrease of
GLUT3 mRNA expression upon differentiation is consistent
with a phenotypic change from colon-carcinoma-like into a
non-tumor like epithelial cell. The over-expression of S-
protein, a cell adhesion-promoting plasma and tissue protein,
compared to intestinal tissues, and the increased mRNA ex-
pression upon differentiation in Caco-2 cells indicate that cell
adhesion mechanisms are crucial in Caco-2 cell differentia-
tion. Overall, upon differentiation, Caco-2 cells become more
similar to small intestinal cells (Tables V and VI). Many genes
were similarly expressed in these two tissues, i.e., their rela-
tive mRNA expression values were below the cut-off 0.45 of
the log ratio values. Similarly, Engle et al. (13) showed that
after reaching confluence, Caco-2 cells expressed proteins
characteristic of colonocytes and small intestinal enterocytes.
Thereafter, the content of colonocyte-specific proteins de-
creased, whereas those specific for the enterocytes increased.
However, a number of genes appear to be differently
expressed in Caco-2 cells compared to the small intestine and
colon.
As to members of the ABC transporter, the monocar-
boxylic acid transporter, and the dipeptides transporter fam-
ily, well-known transporters that act as carriers of a variety of
drugs, we observed significant mRNA expression changes
only for a few ABC transporters during differentiation. Un-
der less stringent but still significant criteria, hPept1 was ex-
pressed less in the colon than in 3-week-old Caco-2 cells,
whereas it was more highly expressed in the small intestine,
which confirms earlier studies (17,34). As for the monocar-
boxylic acid transporters we were unable to observe any sig-
nificant changes during differentiation, or among the tissues
examined. It needs to be kept in mind that the use of mRNA
expression arrays—although providing a global picture of the
mRNA expression of multiple genes—is less sensitive than
other methods such as RT-PCR.
In summary, we have characterized the mRNA expres-
sion profiles of numerous genes encoding transporters and
ion channels, in differentiating Caco-2 cells and human small
intestine and colon. The list of genes and oligonucleotide
probes will be available elsewhere (AAPS PharmSci, URL to
be provided). Fully differentiated Caco-2 cells can serve as a
useful model for studying active drug transport, but the ex-
pression of a number of transporters does not appear to re-
flect mRNA levels in human intestines.
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